Latest news
GoodRx Holdings, Inc. Stock 12‑Month Price Target Raised to $3.7 - TradingViewTradingView · Fri, 07 Aug 2026 10:21:23 GMTGDRX: Pharma Direct and subscriptions drove Q2 outperformance, leading to raised 2026 guidance - TradingViewTradingView · Thu, 06 Aug 2026 14:00:44 GMTGoodRx Holdings, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 22:15:39 GMTGDRX: Pharma Direct and subscription growth drove raised 2026 guidance despite lower transactions - TradingViewTradingView · Wed, 05 Aug 2026 20:33:39 GMTGDRX: Revenue declines as Pharma Direct and subscriptions grow, but legal and market risks remain high - TradingViewTradingView · Wed, 05 Aug 2026 20:21:25 GMTGoodRx Holdings, Inc. 2026: Revenue $200.41M, EPS $0.02— 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 20:11:00 GMTGDRX Q2'26 Earnings: EPS estimate is 0.08 USD - TradingViewTradingView · Tue, 04 Aug 2026 11:01:14 GMTGoodRx Holdings, Inc. Revenue Breakdown – NASDAQ:GDRX - TradingViewTradingView · Tue, 28 Jul 2026 20:30:34 GMT